News | November 07, 2011

EUROECHO Meeting Now Includes MRI, CT and Nuclear Imaging

November 7, 2011 — This year’s annual meeting of the European Association of Echocardiography (EAE), a registered branch of the European Society of Cardiology (ESC), is changing its name to “EUROECHO & other Imaging Modalities.”

EAE President Luigi Badano, M.D., FESC, from the University of Padua, Italy, explains, “To manage cardiac patients today we need to acquire information from all the different imaging modalities, not just echo. As an association of the ESC, the EAE’s philosophy is that we want to become more patient-oriented, rather than pure technology-oriented, so that we’re using the most appropriate technology to address individual clinical questions.”

In addition to echocardiography (ECG), he adds, the meeting will now include magnetic resonance imaging (MRI), computed tomography (CT) and nuclear imaging.

The meeting expects to attract more than 3,000 delegates from 87 countries including cardiologists, internists, cardiac surgeons and sonographers. Seven parallel sessions will run across four days.

“The conference represents a unique opportunity for cardiovascular imagers to come together. There will be teaching sessions for those new to the field, advanced techniques for the more experienced and the latest advances will be presented in over 690 posters and abstracts. You’ll get the opportunity to interact with leading imaging experts from all over the world and try out new technology in the exhibition,” says Prof. Patrizio Lancellotti, FESC, EAE president-elect, from the University of Liège, Belgium.

The organizers hope the Eastern European location of the meeting, which is being held for the first time in Budapest, will enable cardiologists from eastern Europe to attend more easily.
 
The main themes of this year’s meeting are valvular heart disease and left ventricular function. In the sessions on valvular heart disease, delegates will learn how risk stratification using the different imaging modalities is allowing identification of asymptomatic patients who will benefit from earlier surgery. 

The role of 3-D ECG in assessing the likelihood of mitral valve repair is growing. Evaluation of left ventricular (LV) size and function was one of the earliest applications of clinical ECG. Now, the evaluation of LV systolic function with new techniques, such as 2-D speckle tracking is allowing identification of patients with subclinical LV dysfunction related to a more advanced stage of valve disease; patients with chemotherapy-induced cardiac toxicity can also be more easily identified.

The clinical imaging sessions are a new clinical track where cases will be presented and discussed. The clinical pathways sessions, back by popular demand, will provide lectures about various state-of-the-art topics; this includes contrast echocardiography, when to use transoesphageal echocardiography, congenital heart disease, and clinical application of 3-D echo.

Challenging cases will follow each session. On the final day, six international leaders in their fields will present meeting highlights.

This year a special focus is being placed on young investigators, with the intention of encouraging their attendance. “Young investigators will be the cardiologists of tomorrow so, what we really need is a way to get them hooked on research to further our field,” says Lancellotti. 

To give a boost to original research by young researchers, the conference has developed a special mentoring program. Delegates under 35 with high scoring abstracts will be given an opportunity to discuss their work with experts in their specific fields of research.  The scheme is already reaping its rewards, with 45 percent of successful abstract submissions this year coming from investigators under 35 years.

Part of the success of the EAE’s youth drive has been the creation of Club 35, an organization set up within the EAE in January 2011 to support young researchers in training. Club 35 will be holding a special session where members will give presentations on valve disease. There will also be dedicated how-to sessions with advice on writing scientific papers, case reports, and abstracts and how to submit oral presentations.

On Friday afternoon a new light-hearted aspect of the program will be ECHO at JEOPARDY. Based on the popular American quiz show format, delegates will see short clinical cases and then be able to pit their wits against the president and past presidents.

At this year’s meeting there will be a new emphasis on communication with an official congress newspaper that will be handed out free to all delegates. Chairs of selected sessions will be submitting reports that will be accessible online.

For more information: www.escardio.org

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
ScImage and Invia Partnership Announced
News | Cardiac PACS| September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging| September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technology | Radiation Dose Management| September 07, 2017
September 7, 2017 — Sapheneia and Scannerside received U.S.
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Overlay Init